InsidersTradesSigma
Follow the CERUS CORPORATION stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €548.1m. The latest transaction was reported on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: CHRYSTAL NIKOLE JENSEN. All data is free.
Analysts rate CERUS CORPORATION Strong Buy (bullish), based on 3 analysts. Average price target: US$4.67.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
CERUS CORPORATION 是一家专注于开发输血安全技术的公司。其目标是降低通过血液传播的感染风险。